|
SerentilDrug - Serentil The trade name of the product as shown on the labeling.
Dosage -
CONCENTRATE; ORAL
Active Ingredient(s) -
Mesoridazine Besylate
Strength -
EQ 25MG BASE/ML
Applicant -
NOVARTIS
New Drug Application (NDA) Number -
016997
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Approved Prior to Jan 1, 1982
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Novartis Pharmaceuticals Corp
Serentil
Mesna 100mg/ml Injectable; Intravenous
Mesna 100mg/ml Injectable; Intravenous Mesnex 100mg/ml Injectable; Intravenous Mesnex 400mg Tablet; Oral Serentil Eq 25mg Base/ml Concentrate; Oral Canasa 1gm Suppository; Rectal Canasa 500mg Suppository; Rectal Rowasa 500mg Suppository; Rectal Asacol 400mg Tablet, Delayed Release; Oral Mesna 100mg/ml Injectable; Intravenous NewDrugInformation |